Skip to main content
Top
Published in: Supportive Care in Cancer 3/2020

01-03-2020 | Glioma | Original Article

Epilepsy education in gliomas: engaging patients and caregivers to improve care

Authors: Andrea Wasilewski, Jennifer Serventi, Chinazom Ibegbu, Thomas Wychowski, Joy Burke, Nimish Mohile

Published in: Supportive Care in Cancer | Issue 3/2020

Login to get access

Abstract

Background

Tumor-related epilepsy (TRE) is the most common cause of hospitalizations in patients with malignant gliomas leading to increased distress and decreased quality of life (QOL) for patients and caregivers.

Purpose

We sought to determine the feasibility of incorporating a structured TRE-specific education intervention into clinical practice while assessing effect on distress and TRE knowledge.

Methods

We prospectively enrolled glioma patients and their caregivers on an IRB-approved study. Subjects underwent a pre-test to assess baseline knowledge regarding seizure management. A neuro-oncology provider guided subjects through a presentation focused on safety and home management of seizures. Seizure-related distress was measured before and after the educational intervention using a distress thermometer. A post-test was completed. At 2 and 6 months, distress was re-assessed and post-tests were repeated. Subject satisfaction was assessed.

Results

Fifty subjects (23 patients, 27 caregivers) were enrolled. Median age was 59. Fifty-seven percent of patients had TRE. Median time to completion was 21.5 min. Median baseline distress scores were 2/10 for patients and 5/10 for caregivers. Distress scores decreased by a mean of 1.5 points and TRE knowledge increased by 2 points for all subjects between the initial and 2-month visit. Ninety-eight percent of subjects strongly agreed that the education was helpful and informative. Caregivers reported more distress despite better baseline seizure knowledge than patients.

Conclusion

Structured TRE education is feasible in patients with gliomas and their caregivers and may be effective in reducing distress. Further prospective studies are warranted to assess effects on hospitalizations, cost, and QOL.
Literature
1.
go back to reference Wychowski T, Wang H, Buniak L, Henry JC, Mohile N (2013) Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of new generations AEDs. Clin Neurol Neurosurg 115(11):2365–2369CrossRef Wychowski T, Wang H, Buniak L, Henry JC, Mohile N (2013) Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of new generations AEDs. Clin Neurol Neurosurg 115(11):2365–2369CrossRef
2.
go back to reference Wasilewski A, Serventi J, Kamalyan L, Wychowski T, Mohile N (2017) Acute care in glioblastoma: the burden and consequences. Neurooncol Pract 4(4):248–254PubMedPubMedCentral Wasilewski A, Serventi J, Kamalyan L, Wychowski T, Mohile N (2017) Acute care in glioblastoma: the burden and consequences. Neurooncol Pract 4(4):248–254PubMedPubMedCentral
3.
go back to reference Heimans JJ, Taphoorn MJB (2002) Impact of brain tumour treatment on quality of life. J Neurol 249(8):955–960CrossRef Heimans JJ, Taphoorn MJB (2002) Impact of brain tumour treatment on quality of life. J Neurol 249(8):955–960CrossRef
4.
go back to reference Klein M, Engelberts NHJ, van der Ploeg HM, Kasteleijn-Nolst Trenité DGA, Aaronson NK, Taphoorn MJB, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54(4):514–520CrossRef Klein M, Engelberts NHJ, van der Ploeg HM, Kasteleijn-Nolst Trenité DGA, Aaronson NK, Taphoorn MJB, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54(4):514–520CrossRef
5.
go back to reference Shin JY, Kizilbash SH, Robinson SI, Uhm JH, Hammack JE, Lachance DH, Buckner JC, Jatoi A (2016) Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neuro-Oncol 128(2):285–291CrossRef Shin JY, Kizilbash SH, Robinson SI, Uhm JH, Hammack JE, Lachance DH, Buckner JC, Jatoi A (2016) Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neuro-Oncol 128(2):285–291CrossRef
6.
go back to reference Arvold ND, Wang Y, Zigler C, Schrag D, Dominici F (2014) Hospitalization burden and survival among older glioblastoma patients. Neuro-Oncology 16(11):1530–1540CrossRef Arvold ND, Wang Y, Zigler C, Schrag D, Dominici F (2014) Hospitalization burden and survival among older glioblastoma patients. Neuro-Oncology 16(11):1530–1540CrossRef
7.
go back to reference Donovan KA, Grassi L, McGinty HL, Jacobsen PB (2014) Validation of the distress thermometer worldwide: state of the science. Psychooncology 23(3):241–250CrossRef Donovan KA, Grassi L, McGinty HL, Jacobsen PB (2014) Validation of the distress thermometer worldwide: state of the science. Psychooncology 23(3):241–250CrossRef
8.
go back to reference Ray S, Bonafede MM, Mohile NA (2014) Treatment patterns, survival, and healthcare costs of patients with malignant gliomas in a large US commercially insured population. Am Health Drug Benefits 7(3):140–149PubMedPubMedCentral Ray S, Bonafede MM, Mohile NA (2014) Treatment patterns, survival, and healthcare costs of patients with malignant gliomas in a large US commercially insured population. Am Health Drug Benefits 7(3):140–149PubMedPubMedCentral
9.
go back to reference Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A, Pompili A, Carapella CM, Cantelmi T (2014) Weight of epilepsy in brain tumor patients. J Neuro-Oncol 118(2):385–393CrossRef Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A, Pompili A, Carapella CM, Cantelmi T (2014) Weight of epilepsy in brain tumor patients. J Neuro-Oncol 118(2):385–393CrossRef
Metadata
Title
Epilepsy education in gliomas: engaging patients and caregivers to improve care
Authors
Andrea Wasilewski
Jennifer Serventi
Chinazom Ibegbu
Thomas Wychowski
Joy Burke
Nimish Mohile
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04968-x

Other articles of this Issue 3/2020

Supportive Care in Cancer 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine